Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

× No keyword cloud information.

10 in total

Review 1. TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.

Authors: K Bailey Freund; Jean-François Korobelnik; Robert Devenyi; Carsten Framme; John Galic; Edward Herbert; Hans Hoerauf; Paolo Lanzetta; Stephan Michels; Paul Mitchell; Jordi Monés; Carl Regillo; Ramin Tadayoni; James Talks; Sebastian Wolf
Journal: Retina Date: 2015-08 Impact factor: 4.256

2. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-04-07 Impact factor: 3.117

3. Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Am J Ophthalmol Date: 2016-11-25 Impact factor: 5.258

4. Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.

Authors: D Călugăru; M Călugăru
Journal: Eye (Lond) Date: 2016-11-04 Impact factor: 3.775

5. Pro-permeability Factors in Diabetic Macular Edema; The Diabetic Macular Edema Treated With Ozurdex Trial.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Am J Ophthalmol Date: 2016-08-18 Impact factor: 5.258

6. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Am J Ophthalmol Date: 2016-06-04 Impact factor: 5.258

7. Comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Eur J Ophthalmol Date: 2016-11-04 Impact factor: 2.597

8. Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2017-07-01 Impact factor: 1.300

9. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors: Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal: Am J Ophthalmol Date: 2009-05-09 Impact factor: 5.258

10. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Authors: Sonja G Karst; Jan Lammer; Christoph Mitsch; Manuela Schober; Janhvi Mehta; Christoph Scholda; Michael Kundi; Katharina Kriechbaum; Ursula Schmidt-Erfurth
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-10-28 Impact factor: 3.117

10 in total